Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia
Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the cl...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Saadah, Omar I. [verfasserIn] Khayat, Ammar [verfasserIn] Alsufyani, Hadeel A. [verfasserIn] Bin-Taleb, Yagoub [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: No title available - 22, Seite 146-150 |
|---|---|
| Übergeordnetes Werk: |
volume:22 ; pages:146-150 |
| DOI / URN: |
10.1016/j.ajg.2021.05.009 |
|---|
| Katalog-ID: |
ELV006241107 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV006241107 | ||
| 003 | DE-627 | ||
| 005 | 20230505161857.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230505s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajg.2021.05.009 |2 doi | |
| 035 | |a (DE-627)ELV006241107 | ||
| 035 | |a (ELSEVIER)S1687-1979(21)00031-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Saadah, Omar I. |e verfasserin |0 (orcid)0000-0002-3744-9907 |4 aut | |
| 245 | 1 | 0 | |a Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia |
| 264 | 1 | |c 2021 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the clinical, biochemical, and outcomes data of a cohort of autoimmune ALDs patients in a tertiary care centre.Patients and methods: This is a cross-sectional study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected in 2007–2018. All cases were 18 years old or younger at the time of diagnosis. The data collection comprised clinical, laboratory, imaging, treatment, and longitudinal follow-up data.Results: Twenty-five patients were identified; 14 (56%) were females. Twenty-one patients (84%) had AIH-1,1 patient (4%) had AIH-2, and 3 patients (12%) had autoimmune sclerosing cholangitis (ASC). An insidious course was found in 21 (84%) cases. Acute hepatitis and fulminant hepatic failure was found to be very rare. Eight cases (32%) had cirrhosis at diagnosis. A total of 20 cases (80%) had complete remission following therapy. The median follow-up period was 45 months. There was no mortality, and only one patient was referred for transplant. Thus, the transplant-free survival was 96%.Conclusions: Our study showed predominance of AIH-1 over AIH-2. Response to treatment in our cohort was found to be similar to the results found in some other key studies. Prognosis and transplant-free survival is better than many published paediatric studies. | ||
| 650 | 4 | |a Autoimmune liver disease | |
| 650 | 4 | |a Autoimmune hepatitis | |
| 650 | 4 | |a Autoimmune sclerosing cholangitis, children | |
| 650 | 4 | |a Saudi Arabia | |
| 700 | 1 | |a Khayat, Ammar |e verfasserin |4 aut | |
| 700 | 1 | |a Alsufyani, Hadeel A. |e verfasserin |4 aut | |
| 700 | 1 | |a Bin-Taleb, Yagoub |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t No title available |g 22, Seite 146-150 |w (DE-627)ELV001249401 |x 1687-1979 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g pages:146-150 |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 951 | |a AR | ||
| 952 | |d 22 |h 146-150 | ||
| author_variant |
o i s oi ois a k ak h a a ha haa y b t ybt |
|---|---|
| matchkey_str |
article:16871979:2021----::adarcuomueiedsaeaecitvsuyfa |
| hierarchy_sort_str |
2021 |
| publishDate |
2021 |
| allfields |
10.1016/j.ajg.2021.05.009 doi (DE-627)ELV006241107 (ELSEVIER)S1687-1979(21)00031-9 DE-627 ger DE-627 rda eng Saadah, Omar I. verfasserin (orcid)0000-0002-3744-9907 aut Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia 2021 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the clinical, biochemical, and outcomes data of a cohort of autoimmune ALDs patients in a tertiary care centre.Patients and methods: This is a cross-sectional study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected in 2007–2018. All cases were 18 years old or younger at the time of diagnosis. The data collection comprised clinical, laboratory, imaging, treatment, and longitudinal follow-up data.Results: Twenty-five patients were identified; 14 (56%) were females. Twenty-one patients (84%) had AIH-1,1 patient (4%) had AIH-2, and 3 patients (12%) had autoimmune sclerosing cholangitis (ASC). An insidious course was found in 21 (84%) cases. Acute hepatitis and fulminant hepatic failure was found to be very rare. Eight cases (32%) had cirrhosis at diagnosis. A total of 20 cases (80%) had complete remission following therapy. The median follow-up period was 45 months. There was no mortality, and only one patient was referred for transplant. Thus, the transplant-free survival was 96%.Conclusions: Our study showed predominance of AIH-1 over AIH-2. Response to treatment in our cohort was found to be similar to the results found in some other key studies. Prognosis and transplant-free survival is better than many published paediatric studies. Autoimmune liver disease Autoimmune hepatitis Autoimmune sclerosing cholangitis, children Saudi Arabia Khayat, Ammar verfasserin aut Alsufyani, Hadeel A. verfasserin aut Bin-Taleb, Yagoub verfasserin aut Enthalten in No title available 22, Seite 146-150 (DE-627)ELV001249401 1687-1979 nnns volume:22 pages:146-150 GBV_USEFLAG_U SYSFLAG_U GBV_ELV AR 22 146-150 |
| spelling |
10.1016/j.ajg.2021.05.009 doi (DE-627)ELV006241107 (ELSEVIER)S1687-1979(21)00031-9 DE-627 ger DE-627 rda eng Saadah, Omar I. verfasserin (orcid)0000-0002-3744-9907 aut Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia 2021 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the clinical, biochemical, and outcomes data of a cohort of autoimmune ALDs patients in a tertiary care centre.Patients and methods: This is a cross-sectional study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected in 2007–2018. All cases were 18 years old or younger at the time of diagnosis. The data collection comprised clinical, laboratory, imaging, treatment, and longitudinal follow-up data.Results: Twenty-five patients were identified; 14 (56%) were females. Twenty-one patients (84%) had AIH-1,1 patient (4%) had AIH-2, and 3 patients (12%) had autoimmune sclerosing cholangitis (ASC). An insidious course was found in 21 (84%) cases. Acute hepatitis and fulminant hepatic failure was found to be very rare. Eight cases (32%) had cirrhosis at diagnosis. A total of 20 cases (80%) had complete remission following therapy. The median follow-up period was 45 months. There was no mortality, and only one patient was referred for transplant. Thus, the transplant-free survival was 96%.Conclusions: Our study showed predominance of AIH-1 over AIH-2. Response to treatment in our cohort was found to be similar to the results found in some other key studies. Prognosis and transplant-free survival is better than many published paediatric studies. Autoimmune liver disease Autoimmune hepatitis Autoimmune sclerosing cholangitis, children Saudi Arabia Khayat, Ammar verfasserin aut Alsufyani, Hadeel A. verfasserin aut Bin-Taleb, Yagoub verfasserin aut Enthalten in No title available 22, Seite 146-150 (DE-627)ELV001249401 1687-1979 nnns volume:22 pages:146-150 GBV_USEFLAG_U SYSFLAG_U GBV_ELV AR 22 146-150 |
| allfields_unstemmed |
10.1016/j.ajg.2021.05.009 doi (DE-627)ELV006241107 (ELSEVIER)S1687-1979(21)00031-9 DE-627 ger DE-627 rda eng Saadah, Omar I. verfasserin (orcid)0000-0002-3744-9907 aut Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia 2021 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the clinical, biochemical, and outcomes data of a cohort of autoimmune ALDs patients in a tertiary care centre.Patients and methods: This is a cross-sectional study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected in 2007–2018. All cases were 18 years old or younger at the time of diagnosis. The data collection comprised clinical, laboratory, imaging, treatment, and longitudinal follow-up data.Results: Twenty-five patients were identified; 14 (56%) were females. Twenty-one patients (84%) had AIH-1,1 patient (4%) had AIH-2, and 3 patients (12%) had autoimmune sclerosing cholangitis (ASC). An insidious course was found in 21 (84%) cases. Acute hepatitis and fulminant hepatic failure was found to be very rare. Eight cases (32%) had cirrhosis at diagnosis. A total of 20 cases (80%) had complete remission following therapy. The median follow-up period was 45 months. There was no mortality, and only one patient was referred for transplant. Thus, the transplant-free survival was 96%.Conclusions: Our study showed predominance of AIH-1 over AIH-2. Response to treatment in our cohort was found to be similar to the results found in some other key studies. Prognosis and transplant-free survival is better than many published paediatric studies. Autoimmune liver disease Autoimmune hepatitis Autoimmune sclerosing cholangitis, children Saudi Arabia Khayat, Ammar verfasserin aut Alsufyani, Hadeel A. verfasserin aut Bin-Taleb, Yagoub verfasserin aut Enthalten in No title available 22, Seite 146-150 (DE-627)ELV001249401 1687-1979 nnns volume:22 pages:146-150 GBV_USEFLAG_U SYSFLAG_U GBV_ELV AR 22 146-150 |
| allfieldsGer |
10.1016/j.ajg.2021.05.009 doi (DE-627)ELV006241107 (ELSEVIER)S1687-1979(21)00031-9 DE-627 ger DE-627 rda eng Saadah, Omar I. verfasserin (orcid)0000-0002-3744-9907 aut Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia 2021 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the clinical, biochemical, and outcomes data of a cohort of autoimmune ALDs patients in a tertiary care centre.Patients and methods: This is a cross-sectional study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected in 2007–2018. All cases were 18 years old or younger at the time of diagnosis. The data collection comprised clinical, laboratory, imaging, treatment, and longitudinal follow-up data.Results: Twenty-five patients were identified; 14 (56%) were females. Twenty-one patients (84%) had AIH-1,1 patient (4%) had AIH-2, and 3 patients (12%) had autoimmune sclerosing cholangitis (ASC). An insidious course was found in 21 (84%) cases. Acute hepatitis and fulminant hepatic failure was found to be very rare. Eight cases (32%) had cirrhosis at diagnosis. A total of 20 cases (80%) had complete remission following therapy. The median follow-up period was 45 months. There was no mortality, and only one patient was referred for transplant. Thus, the transplant-free survival was 96%.Conclusions: Our study showed predominance of AIH-1 over AIH-2. Response to treatment in our cohort was found to be similar to the results found in some other key studies. Prognosis and transplant-free survival is better than many published paediatric studies. Autoimmune liver disease Autoimmune hepatitis Autoimmune sclerosing cholangitis, children Saudi Arabia Khayat, Ammar verfasserin aut Alsufyani, Hadeel A. verfasserin aut Bin-Taleb, Yagoub verfasserin aut Enthalten in No title available 22, Seite 146-150 (DE-627)ELV001249401 1687-1979 nnns volume:22 pages:146-150 GBV_USEFLAG_U SYSFLAG_U GBV_ELV AR 22 146-150 |
| allfieldsSound |
10.1016/j.ajg.2021.05.009 doi (DE-627)ELV006241107 (ELSEVIER)S1687-1979(21)00031-9 DE-627 ger DE-627 rda eng Saadah, Omar I. verfasserin (orcid)0000-0002-3744-9907 aut Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia 2021 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the clinical, biochemical, and outcomes data of a cohort of autoimmune ALDs patients in a tertiary care centre.Patients and methods: This is a cross-sectional study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected in 2007–2018. All cases were 18 years old or younger at the time of diagnosis. The data collection comprised clinical, laboratory, imaging, treatment, and longitudinal follow-up data.Results: Twenty-five patients were identified; 14 (56%) were females. Twenty-one patients (84%) had AIH-1,1 patient (4%) had AIH-2, and 3 patients (12%) had autoimmune sclerosing cholangitis (ASC). An insidious course was found in 21 (84%) cases. Acute hepatitis and fulminant hepatic failure was found to be very rare. Eight cases (32%) had cirrhosis at diagnosis. A total of 20 cases (80%) had complete remission following therapy. The median follow-up period was 45 months. There was no mortality, and only one patient was referred for transplant. Thus, the transplant-free survival was 96%.Conclusions: Our study showed predominance of AIH-1 over AIH-2. Response to treatment in our cohort was found to be similar to the results found in some other key studies. Prognosis and transplant-free survival is better than many published paediatric studies. Autoimmune liver disease Autoimmune hepatitis Autoimmune sclerosing cholangitis, children Saudi Arabia Khayat, Ammar verfasserin aut Alsufyani, Hadeel A. verfasserin aut Bin-Taleb, Yagoub verfasserin aut Enthalten in No title available 22, Seite 146-150 (DE-627)ELV001249401 1687-1979 nnns volume:22 pages:146-150 GBV_USEFLAG_U SYSFLAG_U GBV_ELV AR 22 146-150 |
| language |
English |
| source |
Enthalten in No title available 22, Seite 146-150 volume:22 pages:146-150 |
| sourceStr |
Enthalten in No title available 22, Seite 146-150 volume:22 pages:146-150 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Autoimmune liver disease Autoimmune hepatitis Autoimmune sclerosing cholangitis, children Saudi Arabia |
| isfreeaccess_bool |
false |
| container_title |
No title available |
| authorswithroles_txt_mv |
Saadah, Omar I. @@aut@@ Khayat, Ammar @@aut@@ Alsufyani, Hadeel A. @@aut@@ Bin-Taleb, Yagoub @@aut@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV001249401 |
| id |
ELV006241107 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">ELV006241107</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505161857.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230505s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajg.2021.05.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV006241107</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1687-1979(21)00031-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Saadah, Omar I.</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-3744-9907</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the clinical, biochemical, and outcomes data of a cohort of autoimmune ALDs patients in a tertiary care centre.Patients and methods: This is a cross-sectional study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected in 2007–2018. All cases were 18 years old or younger at the time of diagnosis. The data collection comprised clinical, laboratory, imaging, treatment, and longitudinal follow-up data.Results: Twenty-five patients were identified; 14 (56%) were females. Twenty-one patients (84%) had AIH-1,1 patient (4%) had AIH-2, and 3 patients (12%) had autoimmune sclerosing cholangitis (ASC). An insidious course was found in 21 (84%) cases. Acute hepatitis and fulminant hepatic failure was found to be very rare. Eight cases (32%) had cirrhosis at diagnosis. A total of 20 cases (80%) had complete remission following therapy. The median follow-up period was 45 months. There was no mortality, and only one patient was referred for transplant. Thus, the transplant-free survival was 96%.Conclusions: Our study showed predominance of AIH-1 over AIH-2. Response to treatment in our cohort was found to be similar to the results found in some other key studies. Prognosis and transplant-free survival is better than many published paediatric studies.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Autoimmune liver disease</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Autoimmune hepatitis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Autoimmune sclerosing cholangitis, children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Saudi Arabia</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Khayat, Ammar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alsufyani, Hadeel A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bin-Taleb, Yagoub</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">No title available</subfield><subfield code="g">22, Seite 146-150</subfield><subfield code="w">(DE-627)ELV001249401</subfield><subfield code="x">1687-1979</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:22</subfield><subfield code="g">pages:146-150</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">22</subfield><subfield code="h">146-150</subfield></datafield></record></collection>
|
| author |
Saadah, Omar I. |
| spellingShingle |
Saadah, Omar I. misc Autoimmune liver disease misc Autoimmune hepatitis misc Autoimmune sclerosing cholangitis, children misc Saudi Arabia Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia |
| authorStr |
Saadah, Omar I. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV001249401 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1687-1979 |
| topic_title |
Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia Autoimmune liver disease Autoimmune hepatitis Autoimmune sclerosing cholangitis, children Saudi Arabia |
| topic |
misc Autoimmune liver disease misc Autoimmune hepatitis misc Autoimmune sclerosing cholangitis, children misc Saudi Arabia |
| topic_unstemmed |
misc Autoimmune liver disease misc Autoimmune hepatitis misc Autoimmune sclerosing cholangitis, children misc Saudi Arabia |
| topic_browse |
misc Autoimmune liver disease misc Autoimmune hepatitis misc Autoimmune sclerosing cholangitis, children misc Saudi Arabia |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
No title available |
| hierarchy_parent_id |
ELV001249401 |
| hierarchy_top_title |
No title available |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV001249401 |
| title |
Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia |
| ctrlnum |
(DE-627)ELV006241107 (ELSEVIER)S1687-1979(21)00031-9 |
| title_full |
Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia |
| author_sort |
Saadah, Omar I. |
| journal |
No title available |
| journalStr |
No title available |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
146 |
| author_browse |
Saadah, Omar I. Khayat, Ammar Alsufyani, Hadeel A. Bin-Taleb, Yagoub |
| container_volume |
22 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Saadah, Omar I. |
| doi_str_mv |
10.1016/j.ajg.2021.05.009 |
| normlink |
(ORCID)0000-0002-3744-9907 |
| normlink_prefix_str_mv |
(orcid)0000-0002-3744-9907 |
| author2-role |
verfasserin |
| title_sort |
paediatric autoimmune liver diseases: a descriptive study of patients from saudi arabia |
| title_auth |
Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia |
| abstract |
Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the clinical, biochemical, and outcomes data of a cohort of autoimmune ALDs patients in a tertiary care centre.Patients and methods: This is a cross-sectional study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected in 2007–2018. All cases were 18 years old or younger at the time of diagnosis. The data collection comprised clinical, laboratory, imaging, treatment, and longitudinal follow-up data.Results: Twenty-five patients were identified; 14 (56%) were females. Twenty-one patients (84%) had AIH-1,1 patient (4%) had AIH-2, and 3 patients (12%) had autoimmune sclerosing cholangitis (ASC). An insidious course was found in 21 (84%) cases. Acute hepatitis and fulminant hepatic failure was found to be very rare. Eight cases (32%) had cirrhosis at diagnosis. A total of 20 cases (80%) had complete remission following therapy. The median follow-up period was 45 months. There was no mortality, and only one patient was referred for transplant. Thus, the transplant-free survival was 96%.Conclusions: Our study showed predominance of AIH-1 over AIH-2. Response to treatment in our cohort was found to be similar to the results found in some other key studies. Prognosis and transplant-free survival is better than many published paediatric studies. |
| abstractGer |
Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the clinical, biochemical, and outcomes data of a cohort of autoimmune ALDs patients in a tertiary care centre.Patients and methods: This is a cross-sectional study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected in 2007–2018. All cases were 18 years old or younger at the time of diagnosis. The data collection comprised clinical, laboratory, imaging, treatment, and longitudinal follow-up data.Results: Twenty-five patients were identified; 14 (56%) were females. Twenty-one patients (84%) had AIH-1,1 patient (4%) had AIH-2, and 3 patients (12%) had autoimmune sclerosing cholangitis (ASC). An insidious course was found in 21 (84%) cases. Acute hepatitis and fulminant hepatic failure was found to be very rare. Eight cases (32%) had cirrhosis at diagnosis. A total of 20 cases (80%) had complete remission following therapy. The median follow-up period was 45 months. There was no mortality, and only one patient was referred for transplant. Thus, the transplant-free survival was 96%.Conclusions: Our study showed predominance of AIH-1 over AIH-2. Response to treatment in our cohort was found to be similar to the results found in some other key studies. Prognosis and transplant-free survival is better than many published paediatric studies. |
| abstract_unstemmed |
Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the clinical, biochemical, and outcomes data of a cohort of autoimmune ALDs patients in a tertiary care centre.Patients and methods: This is a cross-sectional study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected in 2007–2018. All cases were 18 years old or younger at the time of diagnosis. The data collection comprised clinical, laboratory, imaging, treatment, and longitudinal follow-up data.Results: Twenty-five patients were identified; 14 (56%) were females. Twenty-one patients (84%) had AIH-1,1 patient (4%) had AIH-2, and 3 patients (12%) had autoimmune sclerosing cholangitis (ASC). An insidious course was found in 21 (84%) cases. Acute hepatitis and fulminant hepatic failure was found to be very rare. Eight cases (32%) had cirrhosis at diagnosis. A total of 20 cases (80%) had complete remission following therapy. The median follow-up period was 45 months. There was no mortality, and only one patient was referred for transplant. Thus, the transplant-free survival was 96%.Conclusions: Our study showed predominance of AIH-1 over AIH-2. Response to treatment in our cohort was found to be similar to the results found in some other key studies. Prognosis and transplant-free survival is better than many published paediatric studies. |
| collection_details |
GBV_USEFLAG_U SYSFLAG_U GBV_ELV |
| title_short |
Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia |
| remote_bool |
true |
| author2 |
Khayat, Ammar Alsufyani, Hadeel A. Bin-Taleb, Yagoub |
| author2Str |
Khayat, Ammar Alsufyani, Hadeel A. Bin-Taleb, Yagoub |
| ppnlink |
ELV001249401 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1016/j.ajg.2021.05.009 |
| up_date |
2024-07-06T20:42:24.806Z |
| _version_ |
1803863766918496256 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">ELV006241107</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505161857.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230505s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajg.2021.05.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV006241107</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1687-1979(21)00031-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Saadah, Omar I.</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-3744-9907</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background and study aims: Autoimmune liver diseases (ALDs) are a clinico-pathologic spectrum of disorders that share some similarities. They are formally classified as autoimmune hepatitis (AIH), isolated autoimmune sclerosing cholangitis (ASC), and the overlap syndrome of these. We describe the clinical, biochemical, and outcomes data of a cohort of autoimmune ALDs patients in a tertiary care centre.Patients and methods: This is a cross-sectional study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected in 2007–2018. All cases were 18 years old or younger at the time of diagnosis. The data collection comprised clinical, laboratory, imaging, treatment, and longitudinal follow-up data.Results: Twenty-five patients were identified; 14 (56%) were females. Twenty-one patients (84%) had AIH-1,1 patient (4%) had AIH-2, and 3 patients (12%) had autoimmune sclerosing cholangitis (ASC). An insidious course was found in 21 (84%) cases. Acute hepatitis and fulminant hepatic failure was found to be very rare. Eight cases (32%) had cirrhosis at diagnosis. A total of 20 cases (80%) had complete remission following therapy. The median follow-up period was 45 months. There was no mortality, and only one patient was referred for transplant. Thus, the transplant-free survival was 96%.Conclusions: Our study showed predominance of AIH-1 over AIH-2. Response to treatment in our cohort was found to be similar to the results found in some other key studies. Prognosis and transplant-free survival is better than many published paediatric studies.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Autoimmune liver disease</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Autoimmune hepatitis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Autoimmune sclerosing cholangitis, children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Saudi Arabia</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Khayat, Ammar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alsufyani, Hadeel A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bin-Taleb, Yagoub</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">No title available</subfield><subfield code="g">22, Seite 146-150</subfield><subfield code="w">(DE-627)ELV001249401</subfield><subfield code="x">1687-1979</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:22</subfield><subfield code="g">pages:146-150</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">22</subfield><subfield code="h">146-150</subfield></datafield></record></collection>
|
| score |
7.400174 |